Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression: A Prospective, Randomized, Double Blind Study

NCT07423273 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.

NCT NCT07423273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07423273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression: A Prospective, Randomized, Double Blind Study
Lead sponsor
Assaf-Harofeh Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
November 8, 2023
Completion date
December 1, 2030
Enrollment
142 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post stroke depression